Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
InMed Pharmaceuticals Inc. - Common Shares
(NQ:
INM
)
0.8000
-0.0200 (-2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about InMed Pharmaceuticals Inc. - Common Shares
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
InMed Pharmaceuticals Committed To Growing Market Reach, Product Portfolio
↗
March 28, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Committed to Growing Market Reach, Product Portfolio
March 28, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio
March 25, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
63 Biggest Movers From Yesterday
↗
March 25, 2022
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...
Via
Benzinga
InMed Pharmaceuticals Makes Changes In Management
↗
March 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Makes Changes in Management
March 18, 2022
Via
Investor Brand Network
InMed Launching Additional Rare Cannabinoids In Response To Demand
↗
March 17, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
InMed (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Demand
March 17, 2022
Via
Investor Brand Network
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management
March 17, 2022
Via
CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Makes Changes in Management
March 17, 2022
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand
March 16, 2022
Via
CannabisNewsWire
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand
March 16, 2022
Via
Investor Brand Network
Topics
Supply Chain
InMed Pharmaceuticals Inc. (NASDAQ: INM) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 10, 2022
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference
March 08, 2022
Via
Investor Brand Network
InMed Pharmaceuticals Expanding Portfolio In Rare Cannabinoid Market
↗
March 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Expanding Portfolio in Rare Cannabinoid Market
March 04, 2022
Via
Investor Brand Network
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market
March 03, 2022
Via
CannabisNewsWire
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market
March 03, 2022
Via
Investor Brand Network
Topics
Supply Chain
InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market
March 02, 2022
Via
CannabisNewsWire
Stocks That Hit 52-Week Lows On Wednesday
↗
March 02, 2022
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...
Via
Benzinga
InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market
March 02, 2022
Via
Investor Brand Network
InMed's Evolution To Commercial Sales Featured In Research Report
↗
February 17, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
InMed’s (NASDAQ: INM) Evolution to Commercial Sales Featured in Research Report
February 17, 2022
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Evolution to Commercial Sales to Health and Wellness Market Featured in Research Report
February 16, 2022
Via
Investor Brand Network
InMed Names BayMedica VP Of Sales, Releases Q2 2022 Report
↗
February 16, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. InMed Pharmaceuticals (NASDAQ: INM), a...
Via
Benzinga
InMed (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report
February 16, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
InMed Pharmaceuticals (INM): Generating Commercial Sales of CBC and CBT
February 16, 2022
LONDON, UK / ACCESSWIRE / February 16, 2022 / InMed Pharmaceuticals' (INM's) Q222 financial results reflect its evolution from a pure-play biotech firm to one with commercial sales to the health and...
From
Edison Investment Research Limited
Via
AccessWire
InMed Positioned To Offer Rare Cannabinoid Manufacturing Technologies
↗
February 15, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names BayMedica VP of Sales, Releases Q2 2022 Report
February 15, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
InMed (NASDAQ: INM) Positioned to Offer Rare Cannabinoid Manufacturing Technologies
February 15, 2022
Via
Investor Brand Network
Topics
Cannabis
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
